Kreitzer Anatol

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kreitzer Anatol's trades of MapLight Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-29 2026-04-27
PlS Planned sale
16,771 -37.0%
125.08
US$4,246,856 		16,771 -37.0% 125.08 US$4,246,856
2026-04-29 2026-04-27
PlS Planned sale
56,339 -42.0%
416.51
US$3,706,718 		56,339 -42.0% 416.51 US$3,706,718
2026-04-29 2026-04-27
PlS Planned sale
15,358 -3.3%
32.94
US$2,089,755 		15,358 -3.3% 32.94 US$2,089,755
2026-04-27 2026-04-27
PrS Proposed sale
45,422
29.76
US$1,351,759 		45,422 29.76 US$1,351,759
2026-04-17 2026-04-15
S Sale
3,316 -1.3%
26.61
US$88,239 		3,316 -1.3% 26.61 US$88,239
2026-04-15 2026-04-15
PrS Proposed sale
5,000
27.02
US$135,100 		5,000 27.02 US$135,100